Vaccine Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Vaccines
Research from X.N. Luo and colleagues provide new insights into vaccines
April 1st, 2009
According to recent research from Lanzhou, People's Republic of China, "Taenia solium is a great threat not only to human health but also to the pig-raising industry. Oncospheral stage-specific 45W proteins are good candidates for the development of anticysticercosis vaccines." "In this study, a recombinant 45W-4B protein was highly produced and used for vaccination. Two animal trials resulted in a significant reduction in parasite burden induced by the definite protein against Asiatic T. solium, up to 97.0% and 98.4%, respectively," wrote X.N. Luo and colleagues. The researchers concluded: "These provide informative results for the development of...
Source: Vaccine Weekly (2009-04-01)
|
